These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26675218)

  • 1. The Role of Carrier Geometry in Overcoming Biological Barriers to Drug Delivery.
    Jordan C; Shuvaev VV; Bailey M; Muzykantov VR; Dziubla TD
    Curr Pharm Des; 2016; 22(9):1259-73. PubMed ID: 26675218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
    Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
    Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevant Physicochemical Descriptors of "Soft Nanomedicines" to Bypass Biological Barriers.
    Nino-Pariente A; Nebot VJ; Vicent MJ
    Curr Pharm Des; 2016; 22(9):1274-91. PubMed ID: 26675217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
    Sarkar A; Fatima I; Jamal QMS; Sayeed U; Khan MKA; Akhtar S; Kamal MA; Farooqui A; Siddiqui MH
    Curr Drug Metab; 2017; 18(2):129-137. PubMed ID: 28088890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel platforms for vascular carriers with controlled geometry.
    Pillai JD; Dunn SS; Napier ME; DeSimone JM
    IUBMB Life; 2011 Aug; 63(8):596-606. PubMed ID: 21721103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering the drug carrier biointerface to overcome biological barriers to drug delivery.
    Finbloom JA; Sousa F; Stevens MM; Desai TA
    Adv Drug Deliv Rev; 2020 Dec; 167():89-108. PubMed ID: 32535139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of injectable drug nanocrystals.
    Fuhrmann K; Gauthier MA; Leroux JC
    Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.
    Battaglia L; Gallarate M
    Expert Opin Drug Deliv; 2012 May; 9(5):497-508. PubMed ID: 22439808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.
    Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
    Eur J Pharm Biopharm; 2017 Jan; 110():70-75. PubMed ID: 27789358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle shape effects in vitro and in vivo.
    Harris BJ; Dalhaimer P
    Front Biosci (Schol Ed); 2012 Jun; 4(4):1344-53. PubMed ID: 22652876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS.
    Gagliardi M; Borri C
    Curr Pharm Des; 2017; 23(3):393-410. PubMed ID: 27799038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
    Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
    Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of nanoparticle shape in cancer drug delivery.
    Truong NP; Whittaker MR; Mak CW; Davis TP
    Expert Opin Drug Deliv; 2015 Jan; 12(1):129-42. PubMed ID: 25138827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-Based Drug Carriers: The Paradox of a Classical "Cargo" Material Becoming a Versatile "Carrier" to Overcome Barriers in Drug Delivery.
    Getts R; Muro S
    Curr Pharm Des; 2016; 22(9):1245-58. PubMed ID: 26675219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes for brain delivery.
    Lai F; Fadda AM; Sinico C
    Expert Opin Drug Deliv; 2013 Jul; 10(7):1003-22. PubMed ID: 23373728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular drug targeting, pharmacokinetics and bioavailability.
    Leucuta SE
    J Drug Target; 2014 Feb; 22(2):95-115. PubMed ID: 24188545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.